atranorin has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borusiewicz, M; Czyż, J; Galanty, A; Karnas, E; Koczurkiewicz, P; Madeja, Z; Michalik, M; Paw, M; Podolak, I; Węgrzyn, M; Wnuk, D | 1 |
| Caggia, S; Cardile, V; Garbarino, J; Piovano, M; Russo, A | 1 |
2 other study(ies) available for atranorin and Cancer of Prostate
| Article | Year |
|---|---|
Usnic acid and atranorin exert selective cytostatic and anti-invasive effects on human prostate and melanoma cancer cells.
Topics: Actins; Antineoplastic Agents; Apoptosis; Benzofurans; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cytostatic Agents; Fibroblasts; Humans; Hydroxybenzoates; Male; Melanoma; Prostatic Neoplasms | 2017 |
Effect of vicanicin and protolichesterinic acid on human prostate cancer cells: role of Hsp70 protein.
Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Comet Assay; Depsides; DNA Fragmentation; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydroxybenzoates; L-Lactate Dehydrogenase; Lactones; Male; Prostatic Neoplasms; Reactive Oxygen Species | 2012 |